Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Fontus Health Ltd, 60 Lichfield Street, Walsall, WS4 2BX, United Kingdom
Trilasym 50 mg/5 ml Oral Solution.
| Pharmaceutical Form |
|---|
|
Oral Solution. Clear, colourless, raspberry-flavoured liquid. |
Each 5 ml of Oral Solution contains 50 mg of amantadine hydrochloride.
Excipient(s) with known effect:
Each 5 ml also contains:
3250 mg of sorbitol (E420)
10 mg of sodium benzoate (E211)
6.5 mg raspberry flavour containing ethanol, propylene glycol (E 1520) and benzyl alcohol
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Amantadine |
Amantadine has been shown to be a low affinity antagonist at the N-methyl-D-aspartate (NMDA) subtype of glutamate receptors. Overactivity of glutamatergic neurotransmission has been implicated in the generation of parkinsonian symptoms. In addition, amantadine specifically inhibits the replication of influenza A viruses at low concentrations. |
| List of Excipients |
|---|
|
Sodium benzoate (E211) |
Type III amber glass bottle with a tamper evident polypropylene child-resistant screw cap with a polyethylene inner liner containing 150ml of solution with a polypropylene dosing cup.
Pack size: 150 ml.
Fontus Health Ltd, 60 Lichfield Street, Walsall, WS4 2BX, United Kingdom
PL 42924/0020
03/05/2019
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
